从2009年到2016年,逆侧乳腺癌和逆侧预防性乳房切除术的趋势
Shana J Kim1, Jasleen Arneja2, Rebecca A G Christensen1
1Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada.
NPJ breast cancer
|June 14, 2025
概括
逆侧乳腺癌 (CBC) 的发病率正在下降,而逆侧预防性乳房切除术 (CPM) 的发病率在单边诊断后正在上升,特别是在高危人群中. 风险水平对于理解这些乳腺癌趋势至关重要.
科学领域:
- 在瘤学瘤学.
- 流行病学 流行病学
- 公共卫生 公共卫生
背景情况:
- 在初始诊断后,逆侧乳腺癌 (CBC) 仍然是一个令人担忧的问题.
- 反侧预防性乳房切除术 (CPM) 是一种减少CBC风险的选择.
- 了解CBC和CPM的趋势对于患者管理和公共卫生战略至关重要.
研究的目的:
- 描述加拿大安大略省CBC和CPM的趋势.
- 根据乳腺癌风险水平分层分析这些趋势.
- 为了告知关于乳腺癌管理的临床和公共卫生决策.
主要方法:
- 来自加拿大安大略省的人口数据的回顾性分析.
- 随着时间的推移,CBC发病率的特征.
- 在单方面诊断乳腺癌后,评估CPM利用率.
- 根据患者风险因素对趋势的分层.
主要成果:
- 观察到CBC发病率的显著下降.
- 确定了CPM费率的同时增加.
- 这些趋势主要是由乳腺癌风险较高的个体驱动的.
- 根据风险分层,发现了趋势的显著差异.
结论:
- 乳腺癌管理策略正在发展,转向CPM,特别是在高风险人群中.
- 风险分层分析对于准确解释CBC和CPM趋势至关重要.
- 进一步的研究应该探索影响乳腺癌护理这些不断变化的趋势的因素.
相关概念视频
Cancer Survival Analysis
334
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
334
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K


